Kim Moretti

1.0k total citations
48 papers, 440 citations indexed

About

Kim Moretti is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kim Moretti has authored 48 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 13 papers in Oncology. Recurrent topics in Kim Moretti's work include Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (31 papers) and Global Cancer Incidence and Screening (10 papers). Kim Moretti is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (31 papers) and Global Cancer Incidence and Screening (10 papers). Kim Moretti collaborates with scholars based in Australia, Ethiopia and New Zealand. Kim Moretti's co-authors include Michael O’Callaghan, Kerri Beckmann, David Roder, Sue Evans, Jeremy Millar, Martin Borg, Andrew Vincent, John W. Miller, John J. McNeil and Tenaw Yimer Tiruye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Kim Moretti

46 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Moretti Australia 13 292 142 103 44 35 48 440
Netty Kinsella United Kingdom 10 357 1.2× 124 0.9× 101 1.0× 90 2.0× 62 1.8× 45 455
William P. McLaughlin United States 3 244 0.8× 125 0.9× 87 0.8× 42 1.0× 51 1.5× 6 357
Randy Vince United States 13 297 1.0× 142 1.0× 50 0.5× 39 0.9× 59 1.7× 48 523
Sebastian Berg Germany 11 165 0.6× 126 0.9× 149 1.4× 37 0.8× 42 1.2× 43 453
Pablo Fernández Spain 6 314 1.1× 94 0.7× 79 0.8× 24 0.5× 42 1.2× 7 380
Tiziana Magnani Italy 11 205 0.7× 138 1.0× 102 1.0× 15 0.3× 31 0.9× 24 386
Ismael Herruzo Spain 9 367 1.3× 113 0.8× 121 1.2× 35 0.8× 65 1.9× 16 509
Alfonso Mariño Spain 11 389 1.3× 130 0.9× 171 1.7× 42 1.0× 51 1.5× 18 609
Rashid K. Sayyid Canada 13 344 1.2× 131 0.9× 120 1.2× 111 2.5× 54 1.5× 57 549
Linda Drevin Sweden 12 356 1.2× 130 0.9× 130 1.3× 92 2.1× 46 1.3× 20 498

Countries citing papers authored by Kim Moretti

Since Specialization
Citations

This map shows the geographic impact of Kim Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Moretti more than expected).

Fields of papers citing papers by Kim Moretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Moretti. The network helps show where Kim Moretti may publish in the future.

Co-authorship network of co-authors of Kim Moretti

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Moretti. A scholar is included among the top collaborators of Kim Moretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Moretti. Kim Moretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Callaghan, Michael, Shahid Ullah, David P. Smith, et al.. (2025). Predicting incontinence and erectile function after prostate cancer surgery: International validation of models. Surgical Oncology. 59. 102194–102194.
2.
Tiruye, Tenaw Yimer, Michael O’Callaghan, Liesel M. FitzGerald, et al.. (2024). Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection. Clinical Genitourinary Cancer. 22(2). 599–609.e2. 5 indexed citations
3.
Borg, Matthew, Michael O’Callaghan, Kim Moretti, & Andrew Vincent. (2024). External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects. BMC Urology. 24(1). 2–2. 1 indexed citations
4.
Tiruye, Tenaw Yimer, David Roder, Liesel M. FitzGerald, et al.. (2024). Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study. The Prostate. 84(12). 1138–1145. 5 indexed citations
5.
Logan, Jessica M., Alexandra Sorvina, I. R. Johnson, et al.. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data. 11(1). 852–852. 2 indexed citations
6.
Tiruye, Tenaw Yimer, et al.. (2023). Factors impacting on sexual function among men on active surveillance for prostate cancer. The Prostate. 83(7). 678–687. 8 indexed citations
7.
Tiruye, Tenaw Yimer, Kerry Ettridge, Michael O’Callaghan, et al.. (2023). Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card. European Journal of Cancer Care. 2023. 1–12. 5 indexed citations
8.
Tiruye, Tenaw Yimer, David Roder, Liesel M. FitzGerald, et al.. (2023). Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer Epidemiology. 88. 102516–102516. 6 indexed citations
9.
Tiruye, Tenaw Yimer, David Roder, Liesel M. FitzGerald, et al.. (2023). Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. Cancer Epidemiology. 87. 102482–102482. 3 indexed citations
10.
Tiruye, Tenaw Yimer, Michael O’Callaghan, Kerry Ettridge, et al.. (2023). Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer. SHILAP Revista de lepidopterología. 5(1). 109–120. 10 indexed citations
11.
O’Callaghan, Michael, Matthew J. Roberts, Kim Moretti, et al.. (2022). Variation in patient reported outcomes following radical prostatectomy: A bi-national registry-based study. Urologic Oncology Seminars and Original Investigations. 41(2). 105.e9–105.e18. 3 indexed citations
12.
Tiruye, Tenaw Yimer, Michael O’Callaghan, Kim Moretti, et al.. (2022). Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urology. 22(1). 169–169. 12 indexed citations
13.
O’Callaghan, Michael, et al.. (2021). PSA response to antiandrogen withdrawal: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 24(3). 826–836. 2 indexed citations
14.
Campbell, Jared M., Michael O’Callaghan, Andrew Vincent, et al.. (2017). Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer. 15(6). 629–634.e8. 7 indexed citations
15.
O’Callaghan, Michael, Jared M. Campbell, Andrew Vincent, et al.. (2017). An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiation Oncology. 12(1). 56–56. 13 indexed citations
16.
O’Callaghan, Michael, et al.. (2017). Prostate cancer outcomes and delays in care. International Urology and Nephrology. 49(3). 449–455. 7 indexed citations
17.
O’Callaghan, Michael, Jared M. Campbell, Andrew Vincent, et al.. (2017). Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity. Prostate Cancer and Prostatic Diseases. 20(4). 378–388. 19 indexed citations
18.
Ruseckaite, Rasa, Kerri Beckmann, Michael O’Callaghan, et al.. (2016). A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease. BMC Cancer. 16(1). 607–607. 22 indexed citations
19.
Gandaglia, Giorgio, Freddie Bray, Matthew R. Cooperberg, et al.. (2015). Prostate Cancer Registries: Current Status and Future Directions. European Urology. 69(6). 998–1012. 52 indexed citations
20.
Moretti, Kim, et al.. (2004). Anuric, obstructive uropathy in the absence of obvious radiological evidence of obstruction. ANZ Journal of Surgery. 74(7). 611–613. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Netty Kinsella Breakdown of academic impact, for papers by William P. McLaughlin Breakdown of academic impact, for papers by Randy Vince Breakdown of academic impact, for papers by Sebastian Berg Breakdown of academic impact, for papers by Pablo Fernández Breakdown of academic impact, for papers by Tiziana Magnani Breakdown of academic impact, for papers by Ismael Herruzo Breakdown of academic impact, for papers by Alfonso Mariño Breakdown of academic impact, for papers by Rashid K. Sayyid Breakdown of academic impact, for papers by Linda Drevin
Rankless by CCL
2026